Low selenium levels in serum and increased concentration in neoplastic tissues in patients with colorectal cancer: Correlation with serum carcinoembryonic antigen

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 3, 2006, Pages 359-360

  Charalabopoulos, Konstantin ^a,b   Kotsalos, Antonios ^a   Karkabounas, Spyridon ^a   Vezyraki, Patrona ^a   Kalfakakou, Vicky ^a   Metsios, Apostolos ^a   Golias, Christos ^a   Charalabopoulos, Alexander ^a,b   Batistatou, Anna ^a   Evangelou, Angelos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Peterborough and Stamford Hospitals ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; SELENIUM;

ADULT; AGED; ARTICLE; CANCER PATIENT; COLON RESECTION; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FLUOROMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; SELENIUM; TUMOR MARKERS, BIOLOGICAL;

EID: 33644598747     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520500287459     Document Type: Article

References (8)

1. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-41.
2. Charalabopoulos K, Karkabounas S, Charalabopoulos AK, Papalimneou V, Ioachim E, Giannakopoulos X. Inhibition of benzo (a) pyrene-induced carcinogenesis by vitamin C alone and by vitaminC/vitamin E and selenium /glutathione. Biol Trace Elem Res 2003;93:201-11.
3. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2:130-4.
4. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S. Selenium, copper, and zinc concentrations in intestinal cancer tissue and in colon and rectum polyps. Biol Trace Elem Res 2003;92:1-10.
5. Fernadez-Banares F, Cabre E, Esteve M, Mingorance MD, Abad-Lacruz A, Lachica M, et al. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 2002;97:2103-8.
6. Baines A, Taylor-Parker M, Goulet AC, Renaud C, Gerner EW, Nelson MA. Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines. Cancer Biol Ther 2002;1:370-4.
7. Altundag K, Silay Ys, Altundag O, Yigitbasi OG, Gundeslioglu O, Gunduz M. Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients. Med Hypotheses 2005;64:1162-5.
8. Cherukuri DP, Goulet AC, Inoue H, Nelson MA. Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-kappaB) in colon cancer cells. Cancer Biol Ther 2005;4:175-80.